Molecular Mechanisms of Nickel-induced Tumorigenicity.

镍诱导致瘤性的分子机制。

基本信息

  • 批准号:
    8601807
  • 负责人:
  • 金额:
    $ 27.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-01 至 2016-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This competitive renewal application will continue examining the molecular mechanisms by which nickel compounds mediate lung carcinogenesis. In particular, this proposal seeks to identify the molecular mechanisms linking nickel-induced lung sustained inflammation to tumorigenicity of human bronchial epithelial cells (HBECs) in vitro and in vivo. Although there is an association between nickel- induced sustained airway inflammation and lung cancer development, the molecular mechanisms linking nickel exposure to the sustained lung chronic inflammation are not understood yet. The studies obtained from the last funding period and preliminary studies demonstrate that nickel exposure results in the activation of the nuclear factor-:B (NF:B), which in turn mediates COX-2 induction. Our studies also show that nickel exposure enables activation of AP-1, which in turn mediates TNF-1 induction. Furthermore, we find that TNF-1 enables COX-2 induction through the NFAT-dependent pathway. In addition, we find that there is crosstalk between the NFAT and NF?B pathways during cellular response to nickel exposure. Thus, the main hypothesis of this renewal proposal is that the NFAT/ NF?B activation and the pro-inflammatory TNF-1 and COX-2 induction will form positive inflammatory feedback loops, which are responsible for the formation and maintenance of sustained chronic lung inflammation and the induction of lung epithelial cell tumorigenicity due to nickel exposure. We propose the following Specific Aims: 1), To test the hypothesis that the inflammatory positive feedback loops being formed by NF?B, NFAT, and TNF1 are responsible for the maintenance of sustained COX-2 induction due to nickel exposure in HBECs; 2), To determine the role of the positive inflammatory feedback loops in the development of tumorigenicity induced by nickel exposure in HBECs.; 3), To assess the central role of TNF-1 in nickel-induced chronic lung inflammation and its mechanisms in vivo. The overall goal of this proposal is to clarify the formation of positive inflammatory feedback loops among NFAT, NF?B, TNF-1 and COX-2, in nickel exposure both in vitro and in vivo, and to determine the role of the positive inflammatory feedback loops in nickel-induced HBECs' tumorigenicity, as well as the central role of TNF-1 in the maintenance of lung sustained chronic inflammation and lung carcinogenesis during nickel exposure in vivo. Success of the proposal will facilitate our understanding of the molecular mechanism(s) that lead to the formation and maintenance of a lung chronic inflammatory microenvironment, and its role in lung carcinogenesis due to nickel exposure. A better understanding of these issues may provide valuable information for the designing of more effective agents for the prevention and therapy of lung cancers. We believe that the proposed contribution of positive inflammatory feedback loop responsible for nickel-induced lung tumorigenicity is novel.
描述(由申请人提供):这项竞争性更新申请将继续研究镍化合物介导肺癌发生的分子机制。特别是,这项建议试图确定镍诱导的肺持续炎症与体内和体外人支气管上皮细胞(HBECs)致瘤性之间的分子机制。尽管镍诱导的持续性呼吸道炎症与肺癌的发生有关,但镍暴露与持续性肺部慢性炎症之间的分子机制尚不清楚。上一次资助期的研究和初步研究表明,镍暴露导致核因子-B(NF:B)的激活,而核因子-B又介导了COX-2的诱导。我们的研究还表明,镍暴露能够激活AP-1,而AP-1又介导了肿瘤坏死因子-1的诱导。此外,我们还发现,肿瘤坏死因子-1通过NFAT依赖的途径诱导COX-2的表达。此外,我们还发现,在细胞对镍暴露的反应过程中,NFAT和NF?B通路之间存在串扰。因此,这一更新建议的主要假设是,NFAT/NF?B的激活和促炎性肿瘤坏死因子-1和环氧合酶-2的诱导将形成正的炎症反馈环,这些环负责持续慢性肺部炎症的形成和维持,并诱导镍暴露所致的肺上皮细胞肿瘤形成。我们提出的具体目标如下:1)验证由NF?B、NFAT和TNF1形成的炎性正反馈环负责维持镍暴露所致HBECs持续的COX-2诱导的假说;2)确定炎性正反馈环在镍诱导的HBECs致瘤性发展中的作用;3)评估肿瘤坏死因子-1在镍诱导的慢性肺炎症中的中心作用及其体内机制。本研究的总体目标是阐明体内和体外镍暴露中NFAT、核因子?B、肿瘤坏死因子-1和环氧合酶-2之间的正向炎症反馈环的形成,确定正向炎症反馈环在镍诱导的血管内皮细胞致瘤性中的作用,以及肿瘤坏死因子-1在体内镍暴露中维持肺持续慢性炎症和肺癌发生中的核心作用。该方案的成功将有助于我们理解导致肺慢性炎症微环境形成和维持的分子机制(S),以及它在镍暴露所致肺癌发生中的作用。更好地了解这些问题可能为设计更有效的肺癌预防和治疗药物提供有价值的信息。我们认为,正向炎症反馈环在镍诱导的肺肿瘤发生中的作用是新的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHUANSHU HUANG其他文献

CHUANSHU HUANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHUANSHU HUANG', 18)}}的其他基金

Novel Role of XIAP in Bladder Cancer Invasion
XIAP 在膀胱癌侵袭中的新作用
  • 批准号:
    8596899
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Reagent/Service Core
试剂/服务核心
  • 批准号:
    8596901
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Reagent/Service Core
试剂/服务核心
  • 批准号:
    9124862
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)
新化合物Isorhapontigenin (ISO)的治疗作用机制
  • 批准号:
    8844225
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)
新化合物Isorhapontigenin (ISO)的治疗作用机制
  • 批准号:
    8555171
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)
新化合物Isorhapontigenin (ISO)的治疗作用机制
  • 批准号:
    9262166
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)
新化合物Isorhapontigenin (ISO)的治疗作用机制
  • 批准号:
    8688975
  • 财政年份:
    2013
  • 资助金额:
    $ 27.15万
  • 项目类别:
Mechanisms of As-Induced Carcinogenesis
砷诱发的致癌机制
  • 批准号:
    7844264
  • 财政年份:
    2006
  • 资助金额:
    $ 27.15万
  • 项目类别:
Molecular Mechanisms of Nickel-Induced Tumorigenicity
镍致肿瘤的分子机制
  • 批准号:
    7114868
  • 财政年份:
    2004
  • 资助金额:
    $ 27.15万
  • 项目类别:
Molecular Mechanisms of Nickel-Induced Tumorigenicity
镍致肿瘤的分子机制
  • 批准号:
    7450914
  • 财政年份:
    2004
  • 资助金额:
    $ 27.15万
  • 项目类别:

相似海外基金

The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
  • 批准号:
    10220574
  • 财政年份:
    2021
  • 资助金额:
    $ 27.15万
  • 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
  • 批准号:
    RGPIN-2016-05827
  • 财政年份:
    2021
  • 资助金额:
    $ 27.15万
  • 项目类别:
    Discovery Grants Program - Individual
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
  • 批准号:
    10413987
  • 财政年份:
    2021
  • 资助金额:
    $ 27.15万
  • 项目类别:
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
  • 批准号:
    10601067
  • 财政年份:
    2021
  • 资助金额:
    $ 27.15万
  • 项目类别:
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
  • 批准号:
    10359823
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
Dietary induction of intestinal alkaline phosphatase intended to detoxify endotoxin and analysis of its mechanism of action.
膳食诱导肠道碱性磷酸酶解毒内毒素及其作用机制分析。
  • 批准号:
    20K05936
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of alkaline phosphatase, a stem cell marker, using human deciduous dental pulp cells derived from the patient with Hypophosphatasia (HPP)
使用源自低磷酸酯酶症 (HPP) 患者的人乳牙牙髓细胞对干细胞标记物碱性磷酸酶进行功能分析
  • 批准号:
    20K10210
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the role of tissue non-specific alkaline phosphatase in osteogenesis for the therapy of hypophosphatasia.
了解组织非特异性碱性磷酸酶在成骨作用中的作用,以治疗低磷酸酯酶症。
  • 批准号:
    20K16894
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
  • 批准号:
    10117265
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
  • 批准号:
    RGPIN-2016-05827
  • 财政年份:
    2020
  • 资助金额:
    $ 27.15万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了